Sitaglimin

Eskayef Pharmaceuticals Limited🇵🇭 Food and Drug Administration - Philippines

Approval Id: 9d2cdd59729f5b8f
Drug Approval Philippines Name: Sitaglimin
Product Name: Sitaglimin
Registration Number: DRP-12881-04
Brand Name: Sitaglimin
Generic Name: Sitagliptin (as phosphate) + Metformin Hydrochloride
Dosage Form: Film-Coated Tablet
Dosage Strength: 50 mg/500 mg
Manufacturer: Eskayef Pharmaceuticals Limited
Importer: Medinova Pharmaceutical Inc.
Distributor: Skymed Pharma Distributor
Company Detail Path: /organization/eskayef-pharmaceuticals-limited
Issuance Date: 23 December 2024
Expiry Date: 24 October 2027
Pharmacologic Category: Antidiabetic Agent (Dipeptidyl peptidase 4 (DPP-4) inhibitor/Biguanide)
Classification: Prescription Drug (Rx)

Approved

Agency

Philippines FDA

Country

🇵🇭

Approval Date

Jul 14, 2025

Approval ID

9d2cdd59729f5b8f

Type

Standard